TRex Bio files for an IPO

TRex Bio is a clinical-stage biopharmaceutical company focused on tissue Treg biology. It discovers and develops immunoregulatory medicines intended to restore immune balance and promote tissue repair for people with autoimmune and inflammatory diseases.